Dongming Han
Beijing, 100049, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Long-term outcomes by clinical and molecular risk stratification in patients with medulloblastoma receiving risk-adapted therapy.
Journal: Med (New York, N.Y.)
Published: April 01, 2025
Targeting TET3 suppresses group 3 medulloblastoma stemness and progression via impairing hypomethylation of Otx2 super-enhancer.
Journal: Cell reports. Medicine
Published: March 07, 2025
Multi-omics approach reveals the impact of prognosis model-related genes on the tumor microenvironment in medulloblastoma.
Journal: Frontiers in oncology
Published: August 08, 2024
Genomic landscape of medulloblastoma subtypes in an Asian cohort.
Journal: Translational cancer research
Published: August 03, 2024
High cellular plasticity state of medulloblastoma local recurrence and distant dissemination.
Journal: Cell reports. Medicine
Published: May 27, 2024
Single-cell transcriptomic sequencing identifies subcutaneous patient-derived xenograft recapitulated medulloblastoma.
Journal: Animal models and experimental medicine
Published: November 08, 2023
Targeted next-generation sequencing reveals the genetic mechanism of Chinese Marfan syndrome cohort with ocular manifestation.
Journal: Molecular genetics & genomic medicine
Published: August 28, 2023
FraudAuditor: A Visual Analytics Approach for Collusive Fraud in Health Insurance.
Journal: IEEE transactions on visualization and computer graphics
Published: April 08, 2023
Showing 1-9 of 9
Last Updated: 09/26/2026